311 related articles for article (PubMed ID: 28151504)
1. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
2. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.
Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A
Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096
[TBL] [Abstract][Full Text] [Related]
3. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
4. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
5. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Lundström E; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Källberg H; Sandling JK; Syvänen AC; Klareskog L; Gunnarsson I; Rönnblom L; Padyukov L; Svenungsson E
Ann Rheum Dis; 2013 Jun; 72(6):1018-25. PubMed ID: 22893315
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
[TBL] [Abstract][Full Text] [Related]
8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
12. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.
Gustafsson JT; Gunnarsson I; Källberg H; Pettersson S; Zickert A; Vikerfors A; Möller S; Rönnelid J; Elvin K; Svenungsson E
Ann Rheum Dis; 2015 Aug; 74(8):1537-43. PubMed ID: 24692586
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular abnormalities in systemic lupus erythematosus patients in echocardiographic assessment].
Ostanek L; Płońska E; Peregud-Pogorzelska M; Mokrzycki K; Brzosko M; Fischer K; Fliciński J
Pol Merkur Lekarski; 2006 Mar; 20(117):305-8. PubMed ID: 16780262
[TBL] [Abstract][Full Text] [Related]
17. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.
Leung WH; Wong KL; Lau CP; Wong CK; Liu HW
Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus.
Toschi V; Motta A; Castelli C; Gibelli S; Cimminiello C; Molaro GL; Gibelli A
Haemostasis; 1993; 23(5):275-83. PubMed ID: 8175049
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies].
Lolli C; Foscoli M; Giofrè R; Tarquinii M; Pasquali S; Toschi GP
G Ital Cardiol; 1993 Nov; 23(11):1125-34. PubMed ID: 8163102
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
